Probiotics, Prebiotics and Synbiotics in Inflammatory Bowel Diseases

Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study

(2021) Oliwia Zakerska-Banaszak et al.   Scientific Reports

ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease

(2020) Stephan C. Bischoff et al.   CLINICAL NUTRITION

Efficacy of faecal microbiota transplantation in Crohn’s disease: a new target treatment?

(2020) Liyuan Xiang et al.   Microbial Biotechnology

Characterization of mucosa-associated Escherichia coli strains isolated from Crohn’s disease patients in Brazil

(2020) Rafaella F. A. Costa et al.   BMC MICROBIOLOGY

The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)—A Critical Review

(2020) Dominika Jakubczyk et al.   Nutrients

Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease – An Overview of Human Studies

(2019) Paulo José Basso et al.   Frontiers in Pharmacology

Fecal microbiota transplant for Crohn disease: A study evaluating safety, efficacy, and microbiome profile

(2019) Liat Gutin et al.   United European Gastroenterology Journal

Fecal microbiota transplantation for ulcerative colitis: a prospective clinical study

(2019) Yan Tian et al.   BMC GASTROENTEROLOGY

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome

(2019) Israr Khan et al.   Pathogens

Increased abundance of proteobacteria in aggressive Crohn’s disease seven years after diagnosis

(2019) M. K. Vester-Andersen et al.   Scientific Reports

A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease

(2019) Qingdong Guan   Journal of Immunology Research

Probiotics for inflammatory bowel diseases: a promising adjuvant treatment

(2018) Audrey Y. Coqueiro et al.   INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION

Nutrition in Pediatric Inflammatory Bowel Disease

(2018) Erasmo Miele et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Prebiotics and Inflammatory Bowel Disease

(2017) Heather E. Rasmussen et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

(2017) Sudarshan Paramsothy et al.   Journal of Crohns & Colitis

TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota

(2017) Sozaburo Ihara et al.   JOURNAL OF GASTROENTEROLOGY

Fungal microbiota dysbiosis in IBD

(2016) Harry Sokol et al.   GUT

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

(2016) Fernando Gomollón et al.   Journal of Crohns & Colitis

Actualización de probióticos, prebióticos y simbióticos en nutrición clínica

(2016) Gabriel Olveira et al.   Endocrinologia y Nutricion

Mucosa-Associated Faecalibacterium prausnitzii Phylotype Richness Is Reduced in Patients with Inflammatory Bowel Disease

(2015) Mireia Lopez-Siles et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

The Probiotic VSL#3 Has Anti-inflammatory Effects and Could Reduce Endoscopic Recurrence After Surgery for Crohn's Disease

(2015) Richard N. Fedorak et al.   Clinical Gastroenterology and Hepatology

Breakthrough Lactobacillus rhamnosus GG bacteremia associated with probiotic use in an adult patient with severe active ulcerative colitis: case report and review of the literature

(2015) Simone Meini et al.   INFECTION

Probiotics, prebiotics and synbiotics- a review

(2015) Kavita. R. Pandey et al.   JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE

The Role of Probiotic Lactic Acid Bacteria and Bifidobacteria in the Prevention and Treatment of Inflammatory Bowel Disease and Other Related Diseases: A Systematic Review of Randomized Human Clinical Trials

(2015) Maria Jose Saez-Lara et al.   Biomed Research International

Sa2000 The Probiotic VSL#3 in Children With Active Crohn Disease

(2015) Andrew S. Day et al.   GASTROENTEROLOGY

Inflammatory Bowel Disease: Etiology, Pathogenesis and Current Therapy

(2014) Joshua Ko et al.   CURRENT PHARMACEUTICAL DESIGN

Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: A double-blind randomized placebo controlled clinical trial

(2014) Andreas Munk Petersen et al.   Journal of Crohns & Colitis

Systematic Review of Complementary and Alternative Medicine Treatments in Inflammatory Bowel Diseases

(2014) J. Langhorst et al.   Journal of Crohns & Colitis

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease

(2014) F.M. Ruemmele et al.   Journal of Crohns & Colitis

The gut microbiota and inflammatory bowel disease

(2014) Katsuyoshi Matsuoka et al.   Seminars in Immunopathology

Inflammatory bowel disease: Pathogenesis

(2014) Yi-Zhen Zhang   WORLD JOURNAL OF GASTROENTEROLOGY

Saccharomyces boulardii Does Not Prevent Relapse of Crohn's Disease

(2013) Arnaud Bourreille et al.   Clinical Gastroenterology and Hepatology

Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis

(2011) S. Oliva et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Synbiotics for inflammatory bowel disease: useful in adults but problematic in paediatrics

(2011) R. Hansen et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease

(2011) J. L. Benjamin et al.   GUT

Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease

(2011) Anna Negroni et al.   INFLAMMATORY BOWEL DISEASES

Probiotics in Inflammatory Bowel Diseases and Associated Conditions

(2011) David Mack   Nutrients

Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study

(2010) Antonio Tursi et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

(2010) Harald Matthes et al.   BMC Complementary and Alternative Medicine

Effect of a Probiotic Preparation (VSL#3) on Induction and Maintenance of Remission in Children With Ulcerative Colitis

(2009) Erasmo Miele et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Starch-entrapped microspheres show a beneficial fermentation profile and decrease in potentially harmful bacteria during in vitro fermentation in faecal microbiota obtained from patients with inflammatory bowel disease

(2009) Devin J. Rose et al.   BRITISH JOURNAL OF NUTRITION

The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative Colitis

(2009) Ajit Sood et al.   Clinical Gastroenterology and Hepatology

Molecular diversity of Escherichia coli in the human gut: New ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohnʼs disease

(2009) Margarita Martinez-Medina et al.   INFLAMMATORY BOWEL DISEASES

Effect of a Low Dose of Dietary Resveratrol on Colon Microbiota, Inflammation and Tissue Damage in a DSS-Induced Colitis Rat Model

(2009) Mar Larrosa et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Probiotics and prebiotics in inflammatory bowel disease: microflora ‘on the scope’

(2008) Dimitrios Damaskos et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Fallstricke bei der Zöliakiediagnostik

(2008) J Henker et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE